Liquavista BV, an Eindhoven, the Netherlands-based provider of a new type of electronic screen technology, has closed a €7m Series D funding round.Investors include...
GyPSii, an Amsterdam, The Netherlands-based provider of real time mobile web technologies and products that connect people, closed an $11m private funding round led...
Lemnis Lighting B.V., a Barneveld, The Netherlands-based LED-lighting maker, raised $35.7m in its Series D financing round.Participants in the round include existing investors and...
SpePharm Holding, BV, a Amsterdam, The Netherlands-based pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines essentially for the hospital...
SpePharm Holding B.V., a Amsterdam, The Netherlands-based pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines throughout Europe, has received...
Layar, an Amsterdam-The Netherlands-based application which displays real time digital information through the camera of a mobile phone, has received an undisclosed investment. The...
Merus, a Utrecht, The Netherlands-based biopharmaceutical company developing a pipeline of human therapeutic antibodies, completed its €21.7m (approximately $30.7m) Series B financing. The round...
FABPulous B.V. a Maastricht-The Netherlands-based developer of a disposable device which allows for rapid semi-quantitative diagnostic testing in blood or plasma, has completed its...
ProFibrix B.V., a Leiden, The Netherlands-based developer of innovative products for hemostasis and regenerative medicine, received a loan of potentially up to €5m from...
Medisse, an Amersfoort and Enschede, the Netherlands-based biomaterials company, closed an undisclosed amount of equity financing.The round was led by BioGeneration Ventures and Crédit...
Gilde Healthcare Partners, a Utrecht, The Netherlands-based private equity firm specializing in healthcare, announced the launch of a new growth capital fund, Gilde Healthcare...
arGEN-X BV, a Rotterdam, The Netherlands-based biopharmaceutical company focused on the discovery and development of human antibodies, announced the successful second closing of its...
